Non-small Cell Lung Adenocarcinoma
3 clinical trials · Condition
◉ Watch Non-small Cell Lung Adenocarcinoma
| Record | Firm | Date |
|---|---|---|
| A Phase 3 Study of Ganetespib in Combination With Docetaxel Versus Docetaxel Alone in Patients With Advanced NSCLC (NCT01798485) | Synta Pharmaceuticals Corp. | 2013-04-01 |
Track Non-small Cell Lung Adenocarcinoma automatically
Every clearance here is in the API, with alerts when new ones post.